Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Digestive Neuroendocrine Tumors × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 32 Gastro-enteropancreatic neuroendocrine tumor 6 Carcinoid Tumor 4 Adenoma, Islet Cell 3 Serotonin Syndrome 2 Parkinson Disease 2 Neuroblastoma 2 Neoplasms 2 Congenital Hyperinsulinism 2 Advanced Gastroenteropancreatic Neuroendocrine Tumor 2 Thymus Neoplasms 1 Pancreatic Neuroendocrine Tumors in MEN1 1 Non functioning pancreatic endocrine tumor 1 Neuroendocrine Tumors in Lung 1 Neuroectodermal Tumors, Primitive 1 Neoplasm Metastasis 1 Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms 1 Lymphoma, Follicular 1 Liposarcoma 1 Lewy Body Disease 1 Insulinoma 1 Hypoglycemia 1 Hyperinsulinism 1 Flushing 1 Fibrosarcoma 1 Disease 1 Digestive Neuroendocrine Tumors 1 Diarrhea 1 Carcinoid Tumors, Intestinal 1 Brain Neoplasms 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02465112 2019-02-28

TERAVECT

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 3 Terminated

Digestive Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡